Reactivation of retinopathy of prematurity six years after intravitreal injection of bevacizumab

We present the case of an asymptomatic child who developed a very late reactivation of ROP 6 years after its successful treat ment with intravitreal bevacizumab. This case reemphasizes the importance of long-term follow-up after anti-VEGF therapy for ROP until retinal vascularization is complete. It also supports investigating the utility of laser photocoagulation for peripheral avascular retina after successful treatment with anti-VEGF injection for type I ROP.

Source: Journal of AAPOS - July 12, 2023 Category: Opthalmology Authors: Anas Yasin, Shruti Sinha, Rachel Smith, Samiksha Fouzdar Jain, Thomas Hejkal, Paul Rychwalski Tags: Short Report Source Type: research